Characterization of the protein ubiquitination response induced by Doxorubicin

Giorgia Mandili1, Amina Khadjavi, Valentina Gallo

  • 1Department of Genetics, Biology and Biochemistry, University of Turin, Turin, Italy. giorgia.mandili@unito.it

The FEBS Journal
|April 28, 2012
PubMed

Insights

Doxorubicin, a chemotherapy drug, damages cancer cell proteins, not just DNA. This protein damage, indicated by ubiquitination, enhances its anti-tumor effects in neuroblastoma cells.

Area of Science:

  • Oncology
  • Molecular Biology
  • Proteomics

Background:

  • Doxorubicin is a widely used chemotherapy agent primarily known for inducing cancer cell apoptosis via DNA damage.
  • Recent studies indicate Doxorubicin triggers a significant heat shock response, and modulating heat shock proteins affects its efficacy.
  • The precise mechanisms underlying Doxorubicin's action, particularly regarding protein modification, require further elucidation.

Purpose of the Study:

  • To investigate the potential role of protein modification, specifically ubiquitination, in Doxorubicin's anti-tumor activity.
  • To analyze the proteomic changes induced by Doxorubicin treatment in neuroblastoma cells.
  • To explore whether Doxorubicin's effects are mediated through direct protein damage.

Main Methods:

  • Proteomic analysis of ubiquitinated proteins in neuroblastoma cells following Doxorubicin treatment.
  • Dose-dependent assessment of protein ubiquitination levels.
  • Comparison of ubiquitination patterns with Bortezomib, a known proteasome inhibitor.
  • Enzyme activity assays for ubiquitinated proteins (lactate dehydrogenase, α-enolase).
  • Analysis of heat shock protein 27 (HSP27) solubility.

Main Results:

  • Nanomolar concentrations of Doxorubicin induced dose-dependent over-ubiquitination of specific proteins without inhibiting the proteasome.
  • Observed ubiquitination patterns were comparable to those induced by Bortezomib.
  • Significant depletion and loss of activity were noted for ubiquitinated enzymes like lactate dehydrogenase and α-enolase.
  • Decreased solubility of HSP27 was observed, suggesting binding to denatured proteins.

Conclusions:

  • Doxorubicin treatment leads to significant protein ubiquitination and functional impairment of enzymes in neuroblastoma cells.
  • These findings support a novel mechanism where Doxorubicin contributes to its anti-tumor effects by directly damaging proteins.
  • The study highlights protein damage as a key, potentially underestimated, aspect of Doxorubicin's mechanism of action.

Related Concept Videos

Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...